Diansong Zhou (Li Zhou)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

University of Southern California (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Southern California

United States

PHD

Publications

Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Diansong Zhou, Steven R Pirie-Shepherd, Abraham Cf Leung, Curigliano Giuseppe
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study. Molecular cancer therapeutics (2023)
John F R Robertson, Abigail Evans, Stephan Henschen, Cliona Clare Kirwan, Ali Jahan, Laura M Kenny, J Michael Dixon, Peter Schmid, Ashutosh Kothari, Omar Mohamed, Peter Andreas Fasching, Kwok Leung Cheung, Rachel Wuerstlein, Danielle Carroll, Teresa Klinowska, Justin P O Lindemann, Alexander MacDonald, Richard Mather, Rhiannon Maudsley, Michele Moschetta, Myria Nikolaou, Martine P Roudier, Tinnu Sarvotham, Gaia Schiavon, Diansong Zhou, Nadia Harbeck
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)